QualityStar, a physician-founded supplement company, is expanding globally with multi-benefit products designed to simplify ...

Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity ...

Light-it, a leading digital health company, introduces Puppeteer, an AI-powered platform poised to redefine the patient-provider relationship. See how it's transforming how providers and patients ...

Aegis Capital Corp. is acting as the sole book-running manager for the Offering on a firm commitment basis. Sichenzia Ross Ference Carmel LLP is acting as counsel to the Company. Kaufman & Canoles, ...

A live webcast of the presentation will be available on the investor section of the Anaptys website at http://ir.anaptysbio.com/events. A replay of the webcast will be available for at least 30 days ...

Knoxville, TN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of ...

LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today issued a letter to shareholders ...

Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th ...

LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday ...

Interested parties may access the live webcast of the presentation by visiting the Investors & Media section of the Cytokinetics website at http://www.cytokinetics.com. The webcast replay will be ...

To schedule a 1on1 investor meeting with Valneva, institutional investors and analysts can contact Valneva’s investor relations department at [email protected].

By integrating Predictive Oncology’s AI-driven small molecule solid tumor expertise with Renovaro’s AI-powered liquid biopsy and cancer vaccine programs, we envision an opportunity to provide patients ...